Anti-idiotype vaccine in colorectal cancer patients.
Anti-idiotype vaccine in colorectal cancer patients.
复制标题
结直肠癌患者的抗独特型疫苗。
DOI:
10.1089/hyb.1993.12.515
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Mastangelo,M
中科院分区:
文献类型:
--
作者:
Herlyn,D;Zaloudik,J;Somasundaram,R;Jacob,L;Benden,A;Mastangelo,M
The colorectal cancer (CRC) associated 40 kD glycoprotein defined by monoclonal antibodies (MAb) C017-1A (1) and GA733 (2), which bind two different epitopes on the antigen (3), is a valuable target for active immunotherapy in these tumors. The antigen is differentially expressedby gastrointestinal carcinomas as opposed to normal tissues of the gastrointestinal tract (1, 4-6). It is not shed by tumors into the patients' circulation (7, 8). Recently, passive immunotherapy of colorectal carcinoma patients with MAb C017-1A, either alone or in combination with GM-CSF, has demonstrated antitumor effects of targeting of this antigen (9, 10). In approaches to active immunotherapy of the C017-1A/GA733 antigen we have developed anti-idiotypic antibodies (Ab2) against anti-CRC MAb C017-1A and GA733 (Abl) in goats (11, 12). Both Ab2 induced in animals anti-anti-idiotypic antibodies (Ab3) that specifically bound to tumor cells and isolated C017-1A/GA733 antigen and shared idiotypes with the Abl (11, 12).
登录
查看更多内容
DOI:
--
发表时间:
1989
期刊:
Immunology series
影响因子:
--
作者:
GrafJr,LH;Ferrone,S
通讯作者:
Ferrone,S
DOI:
10.1126/science.3952496
发表时间:
1986
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Herlyn,D;Ross,AH;Koprowski,H
通讯作者:
Koprowski,H
影响因子:
2.4
作者:
Herlyn,M;Steplewski,Z;Herlyn,D;ClarkJr,WH;Ross,AH;Blaszczyk,M;Pak,KY;Koprowski,H
通讯作者:
Koprowski,H
影响因子:
11.2
作者:
R. Robins;G. Denton;J. Hardcastle;E. Austin;R. W. Baldwin;L. Durrant
通讯作者:
L. Durrant
DOI:
10.1073/pnas.84.22.8055
发表时间:
1987
影响因子:
11.1
作者:
Herlyn,D;Wettendorff,M;Schmoll,E;Iliopoulos,D;Schedel,I;Dreikhausen,U;Raab,R;Ross,AH;Jaksche,H;Scriba,M
通讯作者:
Scriba,M